STAGE 1-3

Clinical trials for STAGE 1-3 explained in plain language.

Never miss a new study

Get alerted when new STAGE 1-3 trials appear

Sign up with your email to follow new studies for STAGE 1-3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Immune drug combo aims to wipe out breast tumors before surgery

Disease control Not yet recruiting

This study tests whether adding an immune-boosting drug called eftilagimod alpha to standard chemotherapy can make breast tumors disappear completely before surgery in people with early-stage HR+/HER2- breast cancer. About 50 participants will receive the drug combination, and re…

Matched conditions: STAGE 1-3

Phase: PHASE2 • Sponsor: George Washington University • Aim: Disease control

Last updated May 26, 2026 12:12 UTC

STAGE 1-3

Get alerted when new STAGE 1-3 trials appear

Immune drug combo aims to wipe out breast tumors before surgery